Immunology Seminar Series, Seppo Meri
May 18th at 14:00
Virtual event
Seppo Meri, University of Helsinki: Role of complement in pregnancy disorders
Host: Riitta Lahesmaa ( rilahes@utu.fi )
Register latest May 17th at: https://link.webropolsurveys.com/S/0B9738AEBC03A3C1
Zoom link and iCalendar invitation to join the online event will be sent to all registered participants one day before the event.
Registration to this event closes May 17th at 12:00.
Immunology seminar series is jointly organised by Finnish Society for Immunology, InFLAMES Flagship and Turku Bioscience.
For further information contact Anne Lahdenperä ( ankahy@utu.fi ) or Riitta Lahesmaa ( rilahes@utu.fi ), University of Turku
Seppo Meri, MD, PhD, is Professor of Immunology at the Medical Faculty, University of Helsinki, Finland, and the Chief Physician of Research in Microbiology at HUSLAB, laboratory of the Helsinki University Hospital. He is also a visiting professor at the Humanitas University, Milan, Italy. His medical specialty is in Clinical Microbiology.
Professor Meri served as a postdoctoral fellow at the University of Texas in 1988 and in 1989–90 as an EMBO fellow at MRC, Cambridge, UK. His research interests include diseases related to disturbances in complement regulation and reasons for increased susceptibility to microbial infections. He has published ≈ 270 original research articles and 130 reviews or textbook chapters on complement, autoimmunity and microbial escape of immunity.
He has been the President of the Scandinavian Society for Immunology 2001-2007 and of the European Complement Network 2001-2003. He served as the Secretary General of the International Union of Immunological Societies 2010-2016 and as a member of the FEBS Publication Committee 2014-2018. He is a Member of the Finnish Academy of Science and Letters since 2009.
Selected publications:
Reichhardt MP, Lundin K, Lokki AI, Recher G, Vuoristo S, Katayama S, Tapanainen JS, Kere J, Meri S*, Tuuri T*. Complement in human pre-implantation embryos: Attack and defense. Front Immunol. 10:2234, 2019. doi: 10.3389/fimmu.2019.02234
Teirilä L, Heikkinen-Eloranta J, Kotimaa J, Meri S, Lokki AI. Regulation of the complement system and immunological tolerance in pregnancy. Semin Immunol. 45:101337, 2019. doi: 10.1016/j.smim.2019.101337
Kaartinen K, Martola L, Aaltonen S, Meri S. Diagnostic Dilemma of Thrombotic Microangiopathy in Pregnancy. Kidney Int Rep. 6:529-533, 2020. doi: 10.1016/j.ekir.2020.10.036
Lokki AI, Teirilä L, Triebwasser M, Daly E, Bhattacharjee A, Uotila L, Llort Asens M, Kurki MI, Perola M, Auro K, Salmon JE, Daly M, Atkinson JP, Laivuori H, Fagerholm S, Meri S; Finnpec. Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic and functional study. BJOG. Feb 4, 2021. doi: 10.1111/1471-0528.16660
Recent Posts
- PFAS levels in mothers’ blood associated with children’s brain structure and function Researchers from the University of Turku and Turku University Hospital, Finland, and Örebro University, Sweden, Read moreOctober 13, 2025
- Professor Laura Elo receives award for outstanding research from the Jenny and Antti Wihuri Foundation The Jenny and Antti Wihuri Foundation awarded Professor of Computational Medicine Laura Elo a €50,000 Read moreOctober 10, 2025
- Recruit your next student at the MSc Thesis Project Expo 2025. Registration is now open! Do you supervise MSc theses in the biosciences? Join the MSc Thesis Project Expo on Read moreOctober 10, 2025
- University of Turku celebrates Professor Shimon Sakaguchi’s Nobel prize Professor Shimon Sakaguchi, winner of the 2025 Nobel Prize in Medicine, is a visiting professor Read moreOctober 7, 2025
- Heidi Isokääntä Successfully Defends Dissertation on Gut Microbiome Development Heidi Isokääntä Successfully Defends Dissertation on Gut Microbiome Deveopment Turku, 26 September 2025 – Bioanalyst Read moreSeptember 29, 2025
- University of Jyväskylä to Award Honorary Doctorate to Johanna Ivaska The University of Jyväskylä will award 11 new honorary doctorates in May 2026. One of Read moreSeptember 26, 2025